Trials / Completed
CompletedNCT03637192
Acute Exposure of High Altitude on Cognitive Function
Acute Exposure to Hypoxia in Precapillary Pulmonary Hypertension: Physiological and Clinical Effects at Rest and During Exercise
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized crossover Trial in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary Hypertension (CTEPH) to assess the acute response to High Altitude (2500m above sea level) on cognitive functions
Detailed description
Low altitude baseline measurements will be performed in Zurich (460m) including Echocardiography, Right heart catheterization, 6 Minute walk test, pulmonary function test, clinical assessment and blood gas analysis. Randomly assigned to the order of testing, the participants will be tested in Low Altitude (Zurich, 470m) and at High Altitude (2500m). During the exposure to High Altitude (Säntis; 2500m above sea level) for approximately 5 hour, the participants will perform cognitive function test . The results will be compared to low altitude in Zurich (470m).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Low altitude: 470m above sea level | Assessment at Low Altitude (in Zurich; 470m above sea level) in order to compare this data with High altitude exposure |
| OTHER | Säntis; 2500m above sea Level | Exposure to High Altitude (Säntis; 2500m above sea level) for approximately 5 hours |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2018-08-17
- Last updated
- 2020-01-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03637192. Inclusion in this directory is not an endorsement.